BRIEF RESEARCH REPORT article
Front. Bacteriol.
Sec. Pathogenesis, Vaccines, and Immunity of Bacterial Infections
Volume 4 - 2025 | doi: 10.3389/fbrio.2025.1578341
Anti-pneumococcal surface protein A antibodies transferred from maternal mice protect offspring against lethal infection with Streptococcus pneumoniae serotype 3
Provisionally accepted
- Osaka University, Suita, Japan
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Streptococcus pneumoniae (S. pneumoniae) causes otitis media, pneumonia, and invasive pneumococcal diseases (IPDs) such as meningitis and septicemia in humans. IPDs are fatal in children and can cause irreversible sequelae such as brain damage and impaired hearing. The introduction of 7-and 13-valent pneumococcal, conjugate, polysaccharide-based vaccines (PCV7, Prevnar 7 ® ; and PCV13, Prevnar 13 ® ) has decreased pediatric IPD infections. However, PCV13 provides limited protection against S. pneumoniae serotype 3. A new candidate pneumococcal vaccine antigen, pneumococcal surface protein A (PspA), which is found in almost all S. pneumoniae serotypes, addresses the drawbacks of CPS-based vaccines. In a previous study, the PspA3+2 protein was developed as a broad-spectrum vaccine candidate that combines PspA clades 2 and 3. We assessed whether vaccinating pregnant mice with PspA3+2 would transfer anti-PspA3+2 antibodies to pups, and if so, whether the transferred antibodies would protect against bacteremia caused by S. pneumoniae serotype 3. A PspA3+2 vaccine containing aluminum hydroxide gel (alum) and cytosine-phosphate-guanosine oligodeoxynucleotide K3 adjuvants induced anti-PspA antibodies in adult female mice, and an enzyme-linked immunosorbent assay revealed anti-PspA antibodies in serum samples from their offspring. Survival rates after lethal infection with S. pneumoniae serotype 3 were significantly higher among these neonates than in negative controls. These findings suggest that anti-PspA3+2 antibodies transferred from maternal mice vaccinated with PspA3+2 protect against bacteremia caused by S. pneumoniae serotype 3 in newborn pups.
Keywords: Streptococcus pneumoniae, Vaccine, lethal bacteremia, prenatal antibody transfer, PspA
Received: 17 Feb 2025; Accepted: 03 Apr 2025.
Copyright: © 2025 Kuroda, Tanaka and Hamaguchi. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Shigeto Hamaguchi, Osaka University, Suita, Japan
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.